SCHEMBL17486246

SCHEMBL17486246

CC1(C)c2ccccc2-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc(-c5ccc6c(c5)C(C)(C)C(C)(C)C6(C)C)nc4)n3)cc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
PDK2 Q15119 3/20 0.33
ALDH1A1 P00352 3/20 0.32
MAPT P10636 3/20 0.32
MEN1 O00255 2/20 0.32
HPGD P15428 2/20 0.32
KMT2A Q03164 2/20 0.32
GLA P06280 2/20 0.32
KDM4E B2RXH2 1/20 0.32
LMNA P02545 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
GAA P10253 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
NPC1 O15118 1/20 0.30
PDGFRB P09619 1/20 0.30
KDR P35968 1/20 0.30
FLT3 P36888 1/20 0.30
RAB9A P51151 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19295140 0.97 PDK2 (0.34) HSD17B1HSD17B2PDK2
SCHEMBL17485971 0.90 HSD17B1 (0.34) HSD17B1HSD17B2PDK2ALDH1A1MAPT
SCHEMBL22037529 0.90 MEN1 (0.40) PDK2ALDH1A1MAPTMEN1HPGD
SCHEMBL22039004 0.89 MEN1 (0.39) PDK2ALDH1A1MAPTMEN1HPGD
SCHEMBL17486227 0.89 HSD17B1 (0.41) HSD17B1HSD17B2ALDH1A1MAPTMEN1
SCHEMBL17486244 0.87 HSD17B1 (0.40) HSD17B1HSD17B2ALDH1A1MAPTMEN1
SCHEMBL22037979 0.85 MEN1 (0.40) HSD17B1HSD17B2PDK2ALDH1A1MAPT
SCHEMBL17485975 0.85 HSD17B1 (0.43) HSD17B1HSD17B2ALDH1A1MAPTMEN1
SCHEMBL17485968 0.85 HSD17B1 (0.43) HSD17B1HSD17B2ALDH1A1MAPTMEN1
SCHEMBL17486324 0.84 NR1H4 (0.37) HSD17B1HSD17B2ALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174890-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-03-13 EP disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
WO-2016015815-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250353-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 HSD17B1 4418/4885HSD17B2 4241/4885PDK2 2330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.